Project Start
1989-10-08
Project End
1994-09-29
Budget Start
1994-09-27
Budget End
1994-09-29
Support Year
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Rochester
Department
Internal Medicine/Medicine
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Rennels, Margaret B; Deloria, Maria A; Pichichero, Michael E et al. (2002) Lack of consistent relationship between quantity of aluminum in diphtheria-tetanus-acellular pertussis vaccines and rates of extensive swelling reactions. Vaccine 20 Suppl 3:S44-7
Shelly, M A; Pichichero, M E; Treanor, J J (2001) Low baseline antibody level to diphtheria is associated with poor response to conjugated pneumococcal vaccine in adults. Scand J Infect Dis 33:542-4
Pichichero, M E; Edwards, K M; Anderson, E L et al. (2000) Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children. Pediatrics 105:e11
Rennels, M B; Deloria, M A; Pichichero, M E et al. (2000) Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics 105:e12
Treanor, J J; Betts, R F (1998) Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects. Vaccine 16:1756-60
Pichichero, M E; Deloria, M A; Rennels, M B et al. (1997) A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pediatrics 100:772-88
Pichichero, M E; Treanor, J (1997) Economic impact of pertussis. Arch Pediatr Adolesc Med 151:35-40
Shelly, M A; Jacoby, H; Riley, G J et al. (1997) Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults. Infect Immun 65:242-7
Clark, H F; Offit, P A; Ellis, R W et al. (1996) WC3 reassortant vaccines in children. Arch Virol Suppl 12:187-98
Treanor, J J; Clark, H F; Pichichero, M et al. (1995) Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants. Pediatr Infect Dis J 14:301-7

Showing the most recent 10 out of 14 publications